| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |